GENE THERAPY SYSTEMS, INC

genlantis is focused on developing reagents for intracellular delivery of biomolecules. its expertise includes delivery of genes, oligonucleotides, sirna, and proteins into a variety of mammalian cells.

Products & Services

  • Transfection
  • Delivery
  • Efficient
  • Reagent
  • Geneporter
  • Neuroporter
  • Neurofect
  • Lipofectamine
  • Fugene
  • Superfect
  • Polyplus
  • Sirna
  • Protein
  • With
  • Welcome
  • Highly
  • Serum
  • Reproducible
  • Jetpei
  • Cells
  • Protocol
  • Results
  • Media
  • Proteins
  • Oligonucleotides
  • Production
  • Studies
  • Vivo
  • Regulatory
  • Large
  • Complies
  • Requirements
  • Versatile
  • Fecturin
  • Souris
  • Invivojetpei
  • Recombinant
  • Free
Year Established 1998
Annual Sales US$1 Million - US$2.5 Million
Business Type Manufacturer

Web Site Results

1EzNUCLEASE enzyme -...
...DNAs and RNAs) into 5'-phosphorylated oligonucleotides that are 1-4 bases long. The

Found any discrepancies in your company profile?
Request to update the information